This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
LAKE FOREST, Ill.,
April 11, 2012 /PRNewswire/ --
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that
John B. Elliot has been named senior vice president, Operations, effective
April 16. In this role, Mr. Elliot will have overall responsibility for Hospira's global operations organization and serve as a member of Hospira's senior leadership team. He will report directly to
F. Michael Ball, chief executive officer.
"John is a seasoned global leader with more than 35 years of broad manufacturing experience across production, logistics and supply, and specific expertise in injectable pharmaceuticals," said Mr. Ball. "With his proven track record in driving improvements in quality, service and operational effectiveness, we're confident John will have an immediate, positive impact as we continue our efforts to deliver high-quality, cost-effective products to customers and ultimately establish our manufacturing operations as a strategic, competitive advantage."
Mr. Elliot, 60, has most recently advised some of the world's largest pharmaceutical companies in his role as an operations consultant. He previously served as president and chairman at Cherokee Pharmaceuticals, LLC (subsequently acquired by Merck & Co.), a U.S.-based active ingredients manufacturing company, where he led the organization from start-up to become a significant competitor in the contract manufacturing marketplace. Prior to Cherokee, Mr. Elliot spent 26 years with GlaxoSmithKline plc (formerly SmithKline Beecham), most recently serving as senior vice president. During his tenure, he held various roles of progressive responsibility in the operations organization and was credited for inculcating a high-performance culture across his plant network.
Under Mr. Elliot's leadership, Hospira will advance its plant remediation strategies and create additional manufacturing capacity, including the construction of a new 1.1 million square-foot, state-of-the-art facility in
India. Mr. Elliot joins an operations leadership team that has recently been strengthened by the addition of top industry talent, including the appointment of
Zena G. Kaufman as Hospira's new senior vice president of Quality in February.
Born and educated in
Scotland, Mr. Elliot earned his bachelor's degree, with honors, in chemical engineering from
Heriot-Watt University in
About HospiraHospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in
Lake Forest, Ill., and has approximately 15,000 employees. Learn more at